Glucose-responsive mesoporous silica nanoparticles to generation of hydrogen peroxide for synergistic cancer starvation and chemistry therapy

References

• Ruttala HB, Chitrapriya N, Kaliraj K, et al. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy. Acta Biomater. 2017;63:135–149. doi:10.1016/j.actbio.2017.09.00228890258
   PubMed Web of Science ®Google Scholar
• Hu Q, Sun W, Wang C, Gu Z. Recent advances of cocktail chemotherapy by combination drug delivery systems. Adv Drug Deliv Rev. 2016;98:19–34. doi:10.1016/j.addr.2015.10.02226546751
   PubMed Web of Science ®Google Scholar
• Gomes AS, Ramos H, Soares J, Saraiva L. p53 and glucose metabolism: an orchestra to be directed in cancer therapy. Pharmacol Res. 2018;131:75–86. doi:10.1016/j.phrs.2018.03.01529580896
   PubMedGoogle Scholar
• DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7(1):11–20. doi:10.1016/j.cmet.2007.10.00218177721
   PubMed Web of Science ®Google Scholar
• Zhang C, Ni D, Liu Y, Yao H, Bu W, Shi J. Magnesium silicide nanoparticles as a deoxygenation agent for cancer starvation therapy. Nat Nanotechnol. 2017;12(4):378–386. doi:10.1038/nnano.2016.28028068318
   PubMedGoogle Scholar
• Khan AY, Noronha SB, Bandyopadhyaya R. Glucose oxidase enzyme immobilized porous silica for improved performance of a glucose biosensor. Biochem Eng J. 2014;91:78–85. doi:10.1016/j.bej.2014.07.011
   Web of Science ®Google Scholar
• Chen Q, Liang C, Sun X, et al. H2O2-responsive liposomal nanoprobe for photoacoustic inflammation imaging and tumor theranostics via in vivo chromogenic assay. Proc Natl Acad Sci USA. 2017;114(21):5343–5348. doi:10.1073/pnas.170197611428484000
   PubMed Web of Science ®Google Scholar
• Lopez-Lazaro M. Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett. 2007;252(1):1–8. doi:10.1016/j.canlet.2006.10.02917150302
   PubMed Web of Science ®Google Scholar
• Aznar E, Oroval M, Pascual L, Murguia JR, Martinez-Manez R, Sancenon F. Gated materials for on-command release of guest molecules. Chem Rev. 2016;116(2):561–718. doi:10.1021/acs.chemrev.5b0045626730615
   PubMed Web of Science ®Google Scholar
• Bildstein L, Dubernet C, Couvreur P. Prodrug-based intracellular delivery of anticancer agents. Adv Drug Deliv Rev. 2011;63(1–2):3–23. doi:10.1016/j.addr.2010.12.00521237228
   PubMed Web of Science ®Google Scholar
• Yang X, Li Y, Li M, Zhang L, Feng L, Zhang N. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer. Cancer Lett. 2013;334(2):338–345. doi:10.1016/j.canlet.2012.07.00222776563
   PubMed Web of Science ®Google Scholar
• Qiu L, Li Z, Qiao M, et al. Self-assembled pH-responsive hyaluronic acid-g-poly(L-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin. Acta Biomater. 2014;10(5):2024–2035. doi:10.1016/j.actbio.2013.12.02524365705
   PubMed Web of Science ®Google Scholar
• Yang JA, Kong WH, Sung DK, et al. Hyaluronic acid-tumor necrosis factor-related apoptosis-inducing ligand conjugate for targeted treatment of liver fibrosis. Acta Biomater. 2015;12:174–182. doi:10.1016/j.actbio.2014.10.00225305513
   PubMed Web of Science ®Google Scholar
• Du X, Yin S, Wang Y, Gu X, Wang G, Li J. Hyaluronic acid-functionalized half-generation of sectorial dendrimers for anticancer drug delivery and enhanced biocompatibility. Carbohydr Polym. 2018;202:513–522. doi:10.1016/j.carbpol.2018.09.01530287030
   PubMed Web of Science ®Google Scholar
• Noh I, Kim HO, Choi J, et al. Co-delivery of paclitaxel and gemcitabine via CD44-targeting nanocarriers as a prodrug with synergistic antitumor activity against human biliary cancer. Biomaterials. 2015;53:763–774. doi:10.1016/j.biomaterials.2015.03.00625890771
   PubMed Web of Science ®Google Scholar
• Sun X, Liu C, Liu D, Li P, Zhang N. Novel biomimetic vectors with endosomal-escape agent enhancing gene transfection efficiency. Int J Pharm. 2012;425(1–2):62–72. doi:10.1016/j.ijpharm.2012.01.01022266532
   PubMedGoogle Scholar
• Yin T, Liu J, Zhao Z, et al. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties. J Control Release. 2016;243:54–68. doi:10.1016/j.jconrel.2016.09.03627702595
   PubMed Web of Science ®Google Scholar
• Jiang T, Mo R, Bellotti A, Zhou J, Gu Z. Gel–liposome-mediated co-delivery of anticancer membrane-associated proteins and small-molecule drugs for enhanced therapeutic efficacy. Adv Funct Mater. 2014;24(16):2295–2304. doi:10.1002/adfm.v24.16
   Web of Science ®Google Scholar
• Pan L, He Q, Liu J, et al. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. J Am Chem Soc. 2012;134(13):5722–5725. doi:10.1021/ja211035w22420312
   PubMed Web of Science ®Google Scholar
• Cheng J, Liu Q, Shuhendler AJ, Rauth AM, Wu XY. Optimizing the design and in vitro evaluation of bioreactive glucose oxidase-microspheres for enhanced cytotoxicity against multidrug resistant breast cancer cells. Colloids Surf B Biointerfaces. 2015;130:164–172. doi:10.1016/j.colsurfb.2015.04.00225896537
   PubMedGoogle Scholar
• Li SY, Cheng H, Xie BR, et al. Cancer cell membrane camouflaged cascade bioreactor for cancer targeted starvation and photodynamic therapy. ACS Nano. 2017;11(7):7006–7018. doi:10.1021/acsnano.7b0253328665106
   PubMed Web of Science ®Google Scholar
• Du X, Yin S, Zhou F, et al. Reduction-sensitive mixed micelles for selective intracellular drug delivery to tumor cells and reversal of multidrug resistance. Int J Pharm. 2018;550(1–2):1–13. doi:10.1016/j.ijpharm.2018.08.01930114451
   PubMedGoogle Scholar
• Xiao L, Xiong X, Sun X, et al. Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles. Biomaterials. 2011;32(22):5148–5157. doi:10.1016/j.biomaterials.2011.03.07121546083
   PubMed Web of Science ®Google Scholar
• Maeda H, Fukuyasu Y, Yoshida S, et al. Fluorescent probes for hydrogen peroxide based on a non-oxidative mechanism. Angew Chem Int Ed Engl. 2004;43(18):2389–2391. doi:10.1002/anie.20045238115114569
   PubMedGoogle Scholar
• Kanzaki H, Shinohara F, Kajiya M, Fukaya S, Miyamoto Y, Nakamura Y. Nuclear nrf2 induction by protein transduction attenuates osteoclastogenesis. Free Radic Biol Med. 2014;77:239–248. doi:10.1016/j.freeradbiomed.2014.09.00625224039
   PubMed Web of Science ®Google Scholar
• Fan W, Lu N, Huang P, et al. Glucose-responsive sequential generation of hydrogen peroxide and nitric oxide for synergistic cancer starving-like/gas therapy. Angew Chem Int Ed Engl. 2017;56(5):1229–1233. doi:10.1002/anie.20161068227936311
   PubMed Web of Science ®Google Scholar
• Zhang R, Feng L, Dong Z, et al. Glucose & oxygen exhausting liposomes for combined cancer starvation and hypoxia-activated therapy. Biomaterials. 2018;162:123–131. doi:10.1016/j.biomaterials.2018.02.00429438880
   PubMed Web of Science ®Google Scholar
• Zhang X, Li F, Guo S, et al. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells. Biomaterials. 2014;35(11):3650–3665. doi:10.1016/j.biomaterials.2014.01.01324462359
   PubMedGoogle Scholar
• Assanhou AG, Li W, Zhang L, et al. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment. Biomaterials. 2015;73:284–295. doi:10.1016/j.biomaterials.2015.09.02226426537
   PubMed Web of Science ®Google Scholar
• Aied A, Greiser U, Pandit A, Wang W. Polymer gene delivery: overcoming the obstacles. Drug Discov Today. 2013;18(21–22):1090–1098. doi:10.1016/j.drudis.2013.06.01423831858
   PubMed Web of Science ®Google Scholar
• Bitoque DB, Am RDC, Silva GA. Insights on the intracellular trafficking of PDMAEMA gene therapy vectors. Mater Sci Eng C Mater Biol Appl. 2018;93:277–288.30274059
   PubMed Web of Science ®Google Scholar
• Zhang X, Sun N, Zheng M, Kim KM. Clathrin-mediated endocytosis is responsible for the lysosomal degradation of dopamine D3 receptor. Biochem Biophys Res Commun. 2016;476(4):245–251. doi:10.1016/j.bbrc.2016.05.10427240955
   PubMedGoogle Scholar
• Wan Y, Moyle PM, Toth I. Endosome escape strategies for improving the efficacy of oligonucleotide delivery systems. Curr Med Chem. 2015;22(29):3326–3346.26303176
   PubMed Web of Science ®Google Scholar
• Syed Abdul Rahman SN, Abdul Wahab N, Abd MSN. In vitro morphological assessment of apoptosis induced by antiproliferative constituents from the rhizomes of curcuma zedoaria. Evid Based Complement Alternat Med. 2013;2013:5–20. doi:10.1155/2013/257108
   Web of Science ®Google Scholar
• Ziegler U, Groscurth P. Morphological features of cell death. News Physiol Sci. 2004;19:124–128.15143207
   PubMedGoogle Scholar
• Bu H, He X, Zhang Z, Yin Q, Yu H, Li Y. A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer. Int J Pharm. 2014;471(1–2):206–213. doi:10.1016/j.ijpharm.2014.05.03924866272
   PubMedGoogle Scholar
• Wang AT, Liang DS, Liu YJ, Qi XR. Roles of ligand and TPGS of micelles in regulating internalization, penetration and accumulation against sensitive or resistant tumor and therapy for multidrug resistant tumors. Biomaterials. 2015;53:160–172. doi:10.1016/j.biomaterials.2015.02.07725890716
   PubMed Web of Science ®Google Scholar
• Yin S, Huai J, Chen X, et al. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid. Acta Biomater. 2015;26:274–285. doi:10.1016/j.actbio.2015.08.02926300335
   PubMed Web of Science ®Google Scholar
• Dong Q, Zhang H, Han Y, et al. Tumor environment differentiated “nanodepot” programmed for site-specific drug shuttling and combinative therapy on metastatic cancer. J Control Release. 2018;283:59–75. doi:10.1016/j.jconrel.2018.05.02729803613
   PubMedGoogle Scholar